Frankfurt - Delayed Quote EUR

Wave Life Sciences Ltd. (1U5.F)

Compare
11.40
+0.30
+(2.70%)
As of 8:16:34 AM GMT+1. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
53,610.00
113,305.00
3,649.00
40,964.00
20,077.00
Operating Expense
205,662.00
181,301.00
166,369.00
167,980.00
173,454.00
Operating Income
-152,052.00
-67,996.00
-162,720.00
-127,016.00
-153,377.00
Net Non Operating Interest Income Expense
--
--
--
--
-16.00
Other Income Expense
9,535.00
9,806.00
1,578.00
4,567.00
2,626.00
Pretax Income
-142,517.00
-58,190.00
-161,142.00
-122,449.00
-150,751.00
Tax Provision
--
-677.00
681.00
-204.00
-841.00
Net Income Common Stockholders
-142,517.00
-57,513.00
-161,823.00
-122,245.00
-149,910.00
Diluted NI Available to Com Stockholders
-142,517.00
-57,513.00
-161,823.00
-122,245.00
-149,910.00
Basic EPS
-1.12
-0.54
-2.05
-2.36
-3.82
Diluted EPS
-1.12
-0.54
-2.05
-2.36
-3.82
Basic Average Shares
125,553.27
106,097.27
78,855.81
51,825.57
39,227.62
Diluted Average Shares
125,553.27
106,097.27
78,855.81
51,825.57
39,227.62
Total Operating Income as Reported
-152,052.00
-67,996.00
-162,720.00
-127,016.00
-153,377.00
Total Expenses
205,662.00
181,301.00
166,369.00
167,980.00
173,454.00
Net Income from Continuing & Discontinued Operation
-142,517.00
-57,513.00
-161,823.00
-122,245.00
-149,910.00
Normalized Income
-150,786.00
-65,345.86
-163,126.93
-122,274.94
-150,474.59
Net Interest Income
--
--
--
--
-16.00
EBIT
-152,052.00
-67,996.00
-162,720.00
-127,016.00
-153,377.00
EBITDA
-143,363.00
-58,790.00
-152,606.00
-117,181.00
-143,394.00
Reconciled Depreciation
8,689.00
9,206.00
10,114.00
9,835.00
9,983.00
Net Income from Continuing Operation Net Minority Interest
-142,517.00
-57,513.00
-161,823.00
-122,245.00
-149,910.00
Total Unusual Items Excluding Goodwill
8,269.00
7,928.00
1,571.00
30.00
568.00
Total Unusual Items
8,269.00
7,928.00
1,571.00
30.00
568.00
Normalized EBITDA
-151,632.00
-66,718.00
-154,177.00
-117,211.00
-143,962.00
Tax Rate for Calcs
--
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
95.14
267.07
0.06
3.41
12/31/2020 - 4/23/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

9IP1.F Rocket Pharmaceuticals, Inc.
9.94
+3.37%
 
0K4.BE Akero Therapeutics Inc
53.72
-0.04%
 
BBZA.F BB Biotech AG Ord
43.15
+1.29%
 
0K4.F Akero Therapeutics, Inc.
53.74
+4.11%
 
COYA Coya Therapeutics, Inc.
5.86
0.00%
 
22UA.DE BioNTech SE
117.90
-0.59%
 
MTEM Molecular Templates, Inc.
0.0003
+200.00%
 
EDSA Edesa Biotech, Inc.
1.8700
-1.06%
 
ANIX Anixa Biosciences, Inc.
2.9200
-0.68%
 
MGNX MacroGenics, Inc.
3.0400
+1.00%